Trial Profile
Phase IV Registry of Etanercept (ENBREL) in Children With Juvenile Rheumatoid Arthritis
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2008
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- 23 Sep 2008 Actual patient number added.
- 23 Sep 2008 Results have been reported at the 15th Paediatric Rheumatology European Congress (PRES).
- 26 Oct 2005 New trial record.